Biphasic Regulation of Transcription Factor Nuclear Factor-B Activity in Human Endothelial Cells by Lysophosphatidylcholine Through Protein Kinase C–Mediated Pathway

From the Division of Cardiology, Department of Medicine, Kumamoto University School of Medicine, Japan.

Correspondence to Kiyotaka Kugiyama, MD, Division of Cardiology, Department of Medicine, Kumamoto University School of Medicine, Honjo 1–1-1, Kumamoto City, Kumamoto, Japan 860. E-mail kiyo{at}gpo.kumamoto-u.ac.jp

Abstract—Lysophosphatidylcholine (lysoPC), which is generated in oxidized LDL (Ox-LDL) and abundantly exists in atherosclerotic arterial walls, has been shown to alter various endothelial functions and induces several endothelial genes expressed in atherosclerotic arterial walls. Nuclear factor-kappa B (NF-B), a pleiotropic transcription factor, plays an important role in regulation of expression of various genes implicated in atherosclerosis. We have previously reported that lysoPC transferred from Ox-LDL to endothelial surface membrane activates endothelial protein kinase C (PKC), leading to modulated endothelial functions. This study was aimed at determining whether lysoPC could modulate activity of transcription factors in cultured human umbilical vein endothelial cells (HUVECs) by using electrophoretic mobility shift assay. LysoPC was found to increase DNA-binding activity of NF-B in HUVECs within 15 minutes, which peaked at 1 to 2 hours and subsequently declined to the baseline level at 6 hours. Lower concentrations (5 to 15 µmol/L) of lysoPC markedly increased NF-B activity, but higher concentration (50 µmol/L) of lysoPC inhibited the activity. Phorbol 12-myristate 13-acetate, a potent activator of PKC, also augmented NF-B activity in HUVECs, mimicking the effects of lysoPC; furthermore, calphostin C and chelerythrine chloride, specific PKC inhibitors, and -tocopherol, a clinically potent PKC inhibitor, suppressed the lysoPC-induced NF-B activation. These results indicate that lysoPC regulates NF-B activity in a biphasic manner dependent on its concentrations and incubation time in human endothelial cells and the endothelial PKC activation may in part be involved in the lysoPC-induced NF-B activation. Thus, the time course and the positive and negative biphasic regulatory actions of lysoPC on NF-B activity in endothelial cells might exhibit a unique effect of lysoPC in arterial walls on the different stages of atherosclerosis.

Key Words: endothelium • atherosclerosis • signal transduction • oxidized LDL • -tocopherol

This article has been cited by other articles:

				F. Huang, P. V. Subbaiah, O. Holian, J. Zhang, A. Johnson, N. Gertzberg, and H. Lum Lysophosphatidylcholine increases endothelial permeability: role of PKC{alpha} and RhoA cross talk Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L176 - L185. [Abstract] [Full Text] [PDF]

				W. Takabe, Y. Kanai, A. Chairoungdua, N. Shibata, S. Toi, M. Kobayashi, T. Kodama, and N. Noguchi Lysophosphatidylcholine Enhances Cytokine Production of Endothelial Cells via Induction of L-Type Amino Acid Transporter 1 and Cell Surface Antigen 4F2 Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1640 - 1645. [Abstract] [Full Text] [PDF]

				O. Ziouzenkova, L. Asatryan, D. Sahady, G. Orasanu, S. Perrey, B. Cutak, T. Hassell, T. E. Akiyama, J. P. Berger, A. Sevanian, et al. Dual Roles for Lipolysis and Oxidation in Peroxisome Proliferation-Activator Receptor Responses to Electronegative Low Density Lipoprotein J. Biol. Chem., October 10, 2003; 278(41): 39874 - 39881. [Abstract] [Full Text] [PDF]

				S.-i. Koide, K. Kugiyama, S. Sugiyama, S.-i. Nakamura, H. Fukushima, O. Honda, M. Yoshimura, and H. Ogawa Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction J. Am. Coll. Cardiol., February 19, 2003; 41(4): 539 - 545. [Abstract] [Full Text] [PDF]

				F. Rose, G. Dahlem, B. Guthmann, F. Grimminger, U. Maus, J. Hanze, N. Duemmer, U. Grandel, W. Seeger, and H. A. Ghofrani Mediator generation and signaling events in alveolar epithelial cells attacked by S. aureusalpha -toxin Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L207 - L214. [Abstract] [Full Text] [PDF]

				P.-Y. Chang, S. Luo, T. Jiang, Y.-T. Lee, S.-C. Lu, P. D. Henry, and C.-H. Chen Oxidized Low-Density Lipoprotein Downregulates Endothelial Basic Fibroblast Growth Factor Through a Pertussis Toxin-Sensitive G-Protein Pathway: Mediator Role of Platelet-Activating Factor-Like Phospholipids Circulation, July 31, 2001; 104(5): 588 - 593. [Abstract] [Full Text] [PDF]

				Y. Rikitake, S. Kawashima, T. Takahashi, T. Ueyama, S. Ishido, N. Inoue, K.-I. Hirata, and M. Yokoyama Regulation of tyrosine phosphorylation of PYK2 in vascular endothelial cells by lysophosphatidylcholine Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H266 - H274. [Abstract] [Full Text] [PDF]

				M. Aoki, T. Nata, R. Morishita, H. Matsushita, H. Nakagami, K. Yamamoto, K. Yamazaki, M. Nakabayashi, T. Ogihara, and Y. Kaneda Endothelial Apoptosis Induced by Oxidative Stress Through Activation of NF-{kappa}B: Antiapoptotic Effect of Antioxidant Agents on Endothelial Cells Hypertension, July 1, 2001; 38(1): 48 - 55. [Abstract] [Full Text] [PDF]

				M. Morimoto, N. Kume, S. Miyamoto, Y. Ueno, H. Kataoka, M. Minami, K. Hayashida, N. Hashimoto, and T. Kita Lysophosphatidylcholine Induces Early Growth Response Factor-1 Expression and Activates the Core Promoter of PDGF-A Chain in Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 771 - 776. [Abstract] [Full Text] [PDF]

				B. Halvorsen, A. C. Staff, T. Henriksen, T. Sawamura, and T. Ranheim 8-iso-Prostaglandin F2{{alpha}} Increases Expression of LOX-1 in JAR Cells Hypertension, April 1, 2001; 37(4): 1184 - 1190. [Abstract] [Full Text] [PDF]

				K. HEERMEIER, W. LEICHT, A. PALMETSHOFER, M. ULLRICH, C. WANNER, and J. GALLE Oxidized LDL Suppresses NF-{{kappa}}B and Overcomes Protection from Apoptosis in Activated Endothelial Cells J. Am. Soc. Nephrol., March 1, 2001; 12(3): 456 - 463. [Abstract] [Full Text]

				E. Bourdon, N. Loreau, J. Davignon, L. Bernier, and D. Blache Involvement of Oxysterols and Lysophosphatidylcholine in the Oxidized LDL-Induced Impairment of Serum Albumin Synthesis by HEPG2 Cells Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2643 - 2650. [Abstract] [Full Text] [PDF]

				R. C. X. Li, P. Ping, J. Zhang, W. B. Wead, X. Cao, J. Gao, Y. Zheng, S. Huang, J. Han, and R. Bolli PKCepsilon modulates NF-kappa B and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1679 - H1689. [Abstract] [Full Text] [PDF]

				H. Doi, K. Kugiyama, H. Oka, S. Sugiyama, N. Ogata, S.-i. Koide, S.-i. Nakamura, and H. Yasue Remnant Lipoproteins Induce Proatherothrombogenic Molecules in Endothelial Cells Through a Redox-Sensitive Mechanism Circulation, August 8, 2000; 102(6): 670 - 676. [Abstract] [Full Text] [PDF]

				H. Matsushita, R. Morishita, T. Nata, M. Aoki, H. Nakagami, Y. Taniyama, K. Yamamoto, J. Higaki, K. Yasufumi, and T. Ogihara Hypoxia-Induced Endothelial Apoptosis Through Nuclear Factor-{kappa}B (NF-{kappa}B)-Mediated bcl-2 Suppression : In Vivo Evidence of the Importance of NF-{kappa}B in Endothelial Cell Regulation Circ. Res., May 12, 2000; 86(9): 974 - 981. [Abstract] [Full Text] [PDF]

				N. Ogata, H. Yamamoto, K. Kugiyama, H. Yasue, and E. Miyamoto Involvement of protein kinase C in superoxide anion-induced activation of nuclear factor-{kappa}B in human endothelial cells Cardiovasc Res, January 14, 2000; 45(2): 513 - 521. [Abstract] [Full Text] [PDF]

				H. Oka, K. Kugiyama, H. Doi, T. Matsumura, H. Shibata, L. A. Miles, S. Sugiyama, and H. Yasue Lysophosphatidylcholine Induces Urokinase-Type Plasminogen Activator and Its Receptor in Human Macrophages Partly Through Redox-Sensitive Pathway Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 244 - 250. [Abstract] [Full Text] [PDF]

				S. K. Sahni, L. C. Turpin, T. L. Brown, and L. A. Sporn Involvement of Protein Kinase C in Rickettsia rickettsii-Induced Transcriptional Activation of the Host Endothelial Cell Infect. Immun., December 1, 1999; 67(12): 6418 - 6423. [Abstract] [Full Text] [PDF]

				G. R. Y. De Meyer, M. F. Hoylaerts, M. M. Kockx, H. Yamamoto, A. G. Herman, and H. Bult Intimal Deposition of Functional von Willebrand Factor in Atherogenesis Arterioscler Thromb Vasc Biol, October 1, 1999; 19(10): 2524 - 2534. [Abstract] [Full Text] [PDF]

				Y. S. Kim, C.-Y. Han, S.-W. Kim, J.-H. Kim, S.-K. Lee, D.-J. Jung, S.-Y. Park, H. Kang, H.-S. Choi, J. W. Lee, et al. The Orphan Nuclear Receptor Small Heterodimer Partner as a Novel Coregulator of Nuclear Factor-kappa B in Oxidized Low Density Lipoprotein-treated Macrophage Cell Line RAW 264.7 J. Biol. Chem., August 31, 2001; 276(36): 33736 - 33740. [Abstract] [Full Text] [PDF]

				D. M. Shih, Y.-R. Xia, X.-P. Wang, E. Miller, L. W. Castellani, G. Subbanagounder, H. Cheroutre, K. F. Faull, J. A. Berliner, J. L. Witztum, et al. Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis J. Biol. Chem., June 2, 2000; 275(23): 17527 - 17535. [Abstract] [Full Text] [PDF]